C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma

Conditions: Lymphoma, B-Cell; CAR-T Interventions: Biological: C752 Sponsors: 920th Hospital of Joint Logistics Support Force of People ' s Liberation Army of China; Shanghai PerHum Therapeutics Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials